CAS: 911222-45-2 - Rabusertib
Descripción:C18H22BrN5O3
- Sinónimos:
- 1-(5-bromo-4-methyl-2-{[(2S)-morpholin-2-yl]methoxy}phenyl)-3-(5-methylpyrazin-2-yl)urea
- 1-[5-bromo-4-methyl-2-S-(morpholin-2-yl-methoxy)-phenyl]-3-(5-methyl-pyrazin-2-yl)-urea
- 1-{5-Bromo-4-methyl-2-[(2S)-2-morpholinylmethoxy]phenyl}-3-(5-methyl-2-pyrazinyl)urea
- 3-{5-bromo-4-methyl-2-[(2S)-morpholin-2-ylmethoxy]phenyl}-1-(5-methylpyrazin-2-yl)urea
- Ly-2603618
- Ly2603618
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
LY2603618 REF: IN-DA00GU45CAS: 911222-45-2 | 98% | A consultar | Jue 05 Dic 24 | |
Rabusertib (LY2603618) REF: 4Z-K-031049CAS: 911222-45-2 | - - - | A consultar | Mar 10 Dic 24 | |
Rabusertib REF: TM-T6084CAS: 911222-45-2 | 98.86% - 99.63% | 36,00 €~928,00 € | Jue 12 Dic 24 | |
LY 2603618 REF: 3D-BL166662CAS: 911222-45-2 | Min. 95% | A consultar | Jue 16 Ene 25 |
Ref: IN-DA00GU45
1g | A consultar | ||
1mg | 41,00 € | ||
5mg | 81,00 € | ||
50mg | 194,00 € | ||
100mg | 309,00 € | ||
250mg | 492,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
Rabusertib (LY2603618)
CAS:911222-45-2
Fórmula:
C18H22N5O3
Forma y color:
Brown Solid
Peso molecular:
436.31
Ref: 4Z-K-031049
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Rabusertib
CAS:911222-45-2
Rabusertib (IC-83) is a chk1 inhibitor in trials for various cancers, including pancreatic and non-small …
Fórmula:
C18H22BrN5O3
Pureza:
98.86% - 99.63%
Forma y color:
Solid
Peso molecular:
436.3
Ref: TM-T6084
5mg | 45,00 € | ||
10mg | 64,00 € | ||
25mg | 115,00 € | ||
50mg | 172,00 € | ||
100mg | 253,00 € | ||
200mg | 368,00 € |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
LY 2603618
CAS:911222-45-2
Inhibitor of Chk1 kinase; anti-neoplastic
Fórmula:
C18H22BrN5O3
Pureza:
Min. 95%
Peso molecular:
436.3 g/mol
Ref: 3D-BL166662
10mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025